Elizabeth Dater Medicis Pharmaceutical Corp MRX-N TOP PICK Apr 09, 2004

Uses Restolane in place of Botox. Demographically very attractive.

Elizabeth Dater

Owned

Unlock Rating

$41.390

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

TOP PICK

Sector that has been out of favour and under owned for some time. Have had a tough 3/4 years and have been going through a restructuring. Starting to see some benefits. Kind of stock portfolio managers like to get into in a slowdown.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Elizabeth Dater Medicis Pharmaceutical Corp MRX-N TOP PICK Apr 09, 2004

You might be interested:

Medicis Pharmaceutical Corp(MRX-N)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Bruce Murray

The Panic-Proof Portfolio (Stockchase Research)

The Weekly Buzzing Stocks by Billy Kawasaki

Chris Blumas

Stockchase Insights